Shares of Johnson & Johnson
slipped 1.33% to $146.26 Tuesday, on what proved to be an all-around grim buying and selling session for the stock market, with the S&P 500 Index
falling 1.40% to three,360.97 and Dow Jones Industrial Common
falling 1.34% to 27,772.76. Johnson & Johnson closed $10.74 under its 52-week excessive ($157.00), which the corporate achieved on April 23rd.
Regardless of its losses, the stock outperformed a few of its rivals Tuesday, as Roche Holding AG Half. Cert.
fell 2.14% to $344.27, Merck & Co. Inc.
fell 1.98% to $79.63, and Pfizer Inc.
fell 1.58% to $36.17. Buying and selling quantity (5.zero M) remained 798,178 under its 50-day common quantity of 5.eight M.